%A Cole,Jeffrey %A Sweatt,Andrew %A Hutson,Susan %D 2012 %J Frontiers in Neuroanatomy %C %F %G English %K BCATm,BCKD,branched chain amino acids,Isoleucine,Leucine,MSUD,TBI,Valine %Q %R 10.3389/fnana.2012.00018 %W %L %M %P %7 %8 2012-May-28 %9 Original Research %+ Dr Jeffrey Cole,Uniformed Services University of the Health Sciences,Neurology,4301 Jones Bridge Road,B-3012,Bethesda,20814,Maryland,United States,cole_jeffrey2@bah.com %# %! Expression of BCATm and BCKD in the rat brain %* %< %T Expression of mitochondrial branched-chain aminotransferase and α-keto-acid dehydrogenase in rat brain: implications for neurotransmitter metabolism %U https://www.frontiersin.org/articles/10.3389/fnana.2012.00018 %V 6 %0 JOURNAL ARTICLE %@ 1662-5129 %X In the brain, metabolism of the essential branched chain amino acids (BCAAs) leucine, isoleucine, and valine, is regulated in part by protein synthesis requirements. Excess BCAAs are catabolized or excreted. The first step in BCAA catabolism is catalyzed by the branched chain aminotransferase (BCAT) isozymes, mitochondrial BCATm and cytosolic BCATc. A product of this reaction, glutamate, is the major excitatory neurotransmitter and precursor of the major inhibitory neurotransmitter γ-aminobutyric acid (GABA). The BCATs are thought to participate in a α-keto-acid nitrogen shuttle that provides nitrogen for synthesis of glutamate from α-ketoglutarate. The branched-chain α-keto acid dehydrogenase enzyme complex (BCKDC) catalyzes the second, irreversible step in BCAA metabolism, which is oxidative decarboxylation of the branched-chain α-keto acid (BCKA) products of the BCAT reaction. Maple Syrup Urine Disease (MSUD) results from genetic defects in BCKDC, which leads to accumulation of toxic levels of BCAAs and BCKAs that result in brain swelling. Immunolocalization of BCATm and BCKDC in rats revealed that BCATm is present in astrocytes in white matter and in neuropil, while BCKDC is expressed only in neurons. BCATm appears uniformly distributed in astrocyte cell bodies throughout the brain. The segregation of BCATm to astrocytes and BCKDC to neurons provides further support for the existence of a BCAA-dependent glial-neuronal nitrogen shuttle since the data show that BCKAs produced by glial BCATm must be exported to neurons. Additionally, the neuronal localization of BCKDC suggests that MSUD is a neuronal defect involving insufficient oxidation of BCKAs, with secondary effects extending beyond the neuron.